Growth cap on UK’s health service branded drugs bill will rise to 4% from 2027
NHS agrees new drug sales deal with global pharmaceutical groups
Recent Posts
- UK government does not know what it spends on consultants, say MPs
- Trump administration’s mixed messaging sparks wild swings in oil markets
- Microsoft backs Anthropic in legal fight with the Pentagon
- US destroys 16 minelayers near Strait of Hormuz, Centcom says
- UK deploys first warship to Cyprus after scrutiny over delays
